The Medical AI Podcast

Waiting for emergency treatment, when you might already be in shock, can be a very distressing and lonely experience. A big part of the problem might be that you are feeling in the dark about what’s happening and how long you’ll be there. An already stressful situation could feel like an eternity. How can AI systems help here? Two men who have commercialised just such a thing are Aaron Patzer and Dr Justin Schrager, founders of the company Vital.

Some have suggested that the medical profession is a force of resistance in AI adoption, that it is prioritizing the protection of jobs, potentially at the cost of patients Is there any truth in that? Or is the medical profession actually protecting patients by resisting an overhasty rush to AI adoption? With me is someone who is perfectly placed to discuss this, Dr Jethro Hubbard. He is a GP. And he was also instrumental in the introduction of the BMA policy on healthcare AI integration.

AI has the potential to revolutionize clinical trials in many ways. It could make the development of new treatments faster, safer, cheaper and more personalised. One company in this space is Owkin, a unicorn startup based in Paris. With me is Dr Félix Balazard, Director of Optimized Development Solutions.

Dr. Harsha Rajasimha, CEO of Jeeva Clinical Trials, specializes in leveraging AI for clinical research efficiency. He discusses how AI can reduce costs and improve success rates in clinical trials, a process often complicated by high failure rates. Rajasimha emphasizes the need for diversity in trials to ensure inclusive healthcare solutions. He shares insights from his journey in creating tech to streamline trials, particularly for rare diseases and cancers. The conversation highlights the balance between AI innovations and the necessity of human oversight.

Counterfeit medications and medical equipment is a huge global fraud. And it is deadly - counterfeit medications can contain incorrect ingredients and even harmful components. So how far is it possible to detect this kind of fraud and how is AI a part of that effort? With me to discuss this is Roei ROY Ganzarski, CEO of Alitheon. The Medical AI Podcast is one of Feedspot's top rated podcasts: https://blog.feedspot.com/uk_ai_podcasts/

Imagine having crippling back pain, but there’s a four month waiting list for a physiotherpist. Alternatively, you have instant access to an AI-based physiotherapy system. 80% of adults have significant back pain at some point, so there’s an excellent chance that this kind of choice is one you will have to make. But can it be made to work? Is the technology ready? Would it be accepted by governments and patients? Are there issues with patient safety? With me is Finn Stevenson, who is working on precisely this idea. He is a former medic, and CEO of Flok Health.

Episode 41: The path to a medical AI holy grail: medical records analysis and automated treatment selection; with Mika Newton, CEO of XCures

Pat Baird is co-chair of the AI committee for the Association for the Advancement of Medical Instrumentation and the International Medical Device Regulators Forum

Episode 37: AI for psychotherapy. With Lindsay McKean, Psychotherapist

The liver is a miracle of physiology, with over 1,000 known functions. This highlights the potential impact of liver dysfunction on various bodily systems. Also, liver disease is a major cause of death globally, and the numbers are on the rise. This adds up to a critical clinical need. Dr Neil Guha is Professor of Hepatology at the University of Nottingham, an NHS consultant and Research scientist. He recently published an excellent paper in the journal of medical AI on a ML model to rate risk for liver disease.